| Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab S Lin, NA Kennedy, A Saifuddin, DM Sandoval, CJ Reynolds, RC Seoane, ... Nature communications 13 (1), 1379, 2022 | 73 | 2022 |
| ECCO guidelines on inflammatory bowel disease and malignancies H Gordon, L Biancone, G Fiorino, KH Katsanos, U Kopylov, E Al Sulais, ... Journal of Crohn's and Colitis 17 (6), 827-854, 2023 | 67 | 2023 |
| Prevention of malaria resurgence in Greece through the association of mass drug administration (MDA) to immigrants from malaria-endemic regions and standard control measures M Tseroni, A Baka, C Kapizioni, G Snounou, S Tsiodras, M Charvalakou, ... PLoS Neglected Tropical Diseases 9 (11), e0004215, 2015 | 33 | 2015 |
| Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4/5 variants in patients with inflammatory bowel disease treated with infliximab and … Z Liu, K Le, X Zhou, JL Alexander, S Lin, C Bewshea, N Chanchlani, ... The Lancet Gastroenterology & Hepatology 8 (2), 145-156, 2023 | 24 | 2023 |
| Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with … I Papaconstantinou, C Kapizioni, E Legaki, E Xourgia, G Karamanolis, ... World Journal of Gastrointestinal Pharmacology and Therapeutics 8 (4), 193, 2017 | 15 | 2017 |
| Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study C Kapizioni, G Koutoufaris, V Ntouli, K Makris, K Milioni, P Kourkoulis, ... European Journal of Gastroenterology & Hepatology 31 (10), 1206-1210, 2019 | 12 | 2019 |
| EUS-Guided Diagnosis of Gastric Subepithelial Lesions, What Is New? T Vasilakis, D Ziogas, G Tziatzios, P Gkolfakis, E Koukoulioti, C Kapizioni, ... Diagnostics 13 (13), 2176, 2023 | 9 | 2023 |
| The burden and management of anemia in Greek patients with inflammatory bowel disease: A retrospective, multicenter, observational study K Foteinogiannopoulou, K Karmiris, G Axiaris, M Velegraki, A Gklavas, ... BMC gastroenterology 21, 1-10, 2021 | 9 | 2021 |
| Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis P Kourkoulis, C Kapizioni, G Michalopoulos, NP Andreou, ... European Journal of Gastroenterology & Hepatology 31 (10), 1173-1183, 2019 | 9 | 2019 |
| Predictors of response to vedolizumab in patients with ulcerative colitis: results from the Greek VEDO-IBD cohort G Bamias, G Kokkotis, M Gizis, C Kapizioni, K Karmiris, E Koureta, ... Digestive Diseases and Sciences, 1-11, 2021 | 7 | 2021 |
| Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13 222 patients within the UK IBD BioResource C Kapizioni, R Desoki, D Lam, K Balendran, E Al-Sulais, S Subramanian, ... Journal of Crohn's and Colitis 18 (6), 790-800, 2024 | 6 | 2024 |
| Results of the Eighth Scientific Workshop of ECCO: prevention and treatment of postoperative recurrence in patients with Crohn’s disease undergoing an ileocolonic resection … M Ferrante, L Pouillon, M Mañosa, E Savarino, M Allez, C Kapizioni, ... Journal of Crohn's and Colitis 17 (11), 1707-1722, 2023 | 6 | 2023 |
| Comparative performance and external validation of three different scores in predicting inadequate bowel preparation among Greek inpatients undergoing colonoscopy P Gkolfakis, C Kapizioni, G Tziatzios, A Facciorusso, L Frazzoni, ... Annals of Gastroenterology 36 (1), 25, 2023 | 2 | 2023 |
| Gastric polyps: a retrospective cohort analysis of 23,668 endoscopies indicates changing epidemiological and phenotypic characteristics C Kapizioni, P Kourkoulis, S Kartsoli, G Koutoufaris, P Giannelis, A Mellos, ... Gastroenterology Review/Przegląd Gastroenterologiczny 19 (1), 54-59, 2024 | 1 | 2024 |
| Comparative effectiveness of vedolizumab and ustekinumab in Crohn's Disease patients who failed anti-TNF treatment: Interrogating 1019 patients from the UK IBD BioResource R Desoki, K Balendran, C Kapizioni, R Shawky, M Parkes, T Raine JOURNAL OF CROHNS & COLITIS 16, I118-I118, 2022 | 1 | 2022 |
| DOP74 Comparative effectiveness of vedolizumab and ustekinumab in Crohn’s disease patients who failed anti-TNF treatment: Interrogating 1019 patients from the UK IBD BioResource R Desoki, K Balendran, C Kapizioni, R Shawky, M Parkes, T Raine Journal of Crohn's and Colitis 16 (Supplement_1), i117-i118, 2022 | 1 | 2022 |
| Is Ustekinumab the best treatment option in patients with Crohn's disease and coexistent multiple sclerosis? C Kapizioni, K Makris, P Kourkoulis, S Vrakas, G Michalopoulos Acta Gastroenterol Belg 82 (2), 337, 2019 | 1 | 2019 |
| Delay in diagnosis of inflammatory bowel diseases and associated factors since the 1980s P Giannelis, G Michalopoulos, S Vrakas, K Makris, C Kapizioni, ... JOURNAL OF CROHNS & COLITIS 13, S153-S153, 2019 | 1 | 2019 |
| ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment H Gordon, S Minozzi, U Kopylov, B Verstockt, M Chaparro, C Buskens, ... Journal of Crohn's and Colitis, jjae091, 2024 | | 2024 |
| Factors affecting the diagnostic accuracy of EUS-FNA for pancreatic and peripancreatic lesions: a single-center experience IS Papanikolaou, A Stamou, E Koukoulioti, C Kapizioni, E Rizos, ... Endoscopy 56 (S 02), eP626, 2024 | | 2024 |
